Device Access

Apollotm

Payments companies reported to CMS as associated with Apollotm. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.7Massociated payments (2023-2025)
288clinicians with associated payments
1company reporting

By year

2023 $466K
2024 $695K
2025 $497K

Payments reported as associated with Apollotm, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurological Surgery $465K
Neurology (Psychiatry & Neurology) $315K
Interventional Cardiology $186K
Cardiovascular Disease $95K
Thoracic Surgery (Cardiothoracic Vascular Surgery) $90K
Internal Medicine $75K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Apollotm

These are the largest totals companies reported as associated with Apollotm. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Michael Caskey Phoenix, AZ $151,069.20
Timothy Byrne Phoenix, AZ Interventional Cardiology $95,313.67
Brent Morel Aurora, CO Neurology (Psychiatry & Neurology) $75,000.00
Neal Duggal Ann Arbor, MI Anesthesiology $61,210.46
Vivek Agrawal San Jose, CA Neuroradiology $60,000.00
Basel Ramlawi Wynnewood, PA Thoracic Surgery (Cardiothoracic Vascular Surgery) $56,185.76
Bhageeradh Mulpur Huntsville, AL Neurology (Psychiatry & Neurology) $50,000.00
Earl Jones Memphis, TN Neurological Surgery $50,000.00
Tyler Scullen New Orleans, LA Neurological Surgery $50,000.00
Hamid Khan Buffalo, NY Neurological Surgery $50,000.00

Prescribed Apollotm?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.